Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Exp Immunol ; 177(2): 478-82, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24593795

RESUMEN

Major long-term complications in patients with diabetes are related to oxidative stress, caused by the hyperglycaemia characteristic for diabetes mellitus. The anti-oxidant coenzyme Q10 (CoQ10) has therefore been proposed as a beneficial supplement to diabetes treatment. Apart from its anti-oxidative function, CoQ10 appears to modulate immune functions by largely unknown mechanisms. The aim of this study was therefore to investigate the effect of CoQ10 on antimicrobial peptides and natural killer (NK) cells, both innate immune components implicated in the pathogenesis of diabetes and diabetes-associated long-term complications such as cardiovascular disease. We determined serum levels of antimicrobial peptides and the phenotype of NK cells isolated from peripheral blood of patients with type 1 (T1DM) or type 2 diabetes mellitus (T2DM) and from healthy controls. In addition, the same parameters were determined in diabetic patients after a 12-week period of CoQ10 supplementation. Two antimicrobial peptides, the human cathelicidin antimicrobial peptide (CAMP) and the human beta defensin 1 (hBD1), were reduced in serum from patients with T1DM. This defect was not reversible by CoQ10 supplementation. In contrast, CoQ10 reduced the levels of circulating hBD2 in these patients and induced changes in subset distribution and activation markers in peripheral NK cells. The results of the present study open up novel approaches in the prevention of long-term complications associated to T1DM, although further investigations are needed.


Asunto(s)
Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 2/inmunología , Diabetes Mellitus Tipo 2/metabolismo , Inmunidad Innata , Ubiquinona/análogos & derivados , Adulto , Anciano , Péptidos Catiónicos Antimicrobianos/sangre , Péptidos Catiónicos Antimicrobianos/metabolismo , Antioxidantes/metabolismo , Antioxidantes/farmacología , Biomarcadores , Estudios de Casos y Controles , Citocinas/biosíntesis , Suplementos Dietéticos , Humanos , Inflamación/inmunología , Inflamación/metabolismo , Células Asesinas Naturales/inmunología , Células Asesinas Naturales/metabolismo , Persona de Mediana Edad , Estrés Oxidativo , Ubiquinona/administración & dosificación , Ubiquinona/metabolismo , Ubiquinona/farmacología , beta-Defensinas/sangre , beta-Defensinas/metabolismo
2.
Free Radic Biol Med ; 29(3-4): 285-94, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11035257

RESUMEN

Interest in ubiquinone (UQ) has increased during recent years, mainly because of its antioxidant function and its use as a dietary supplement. However, our knowledge of the biosynthesis, catabolism, and regulation of this lipid in mammalian tissues is quite limited. UQ exhibits a high rate of turnover in all tissues indicating that cells possess efficient metabolic pathways for handling this compound and controlling its tissue levels. Besides reviewing the generally accepted metabolic pathway, alternative synthetic mechanisms are described. The lack of data concerning catabolism and regulation of this compound is emphasized. Reasons for the rather limited uptake of dietary UQ are discussed and alternative mechanisms for its beneficial effects on organ function are suggested. Since appropriate tissue uptake of dietary UQ probably only occurs in deficient states, the definition of partial UQ deficiency and its consequences is urgently needed. The possibility of raising tissue UQ levels by drug treatment or natural metabolites is raised as a choice of preference for the future.


Asunto(s)
Ubiquinona/metabolismo , Envejecimiento/fisiología , Animales , Antioxidantes/metabolismo , Dieta , Dolicoles/metabolismo , Semivida , Humanos , Metabolismo de los Lípidos , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Neoplasias Hepáticas/metabolismo , Ácido Mevalónico/metabolismo , Estrés Oxidativo , Ubiquinona/administración & dosificación , Ubiquinona/biosíntesis , Ubiquinona/farmacología
3.
Toxicology ; 146(2-3): 161-9, 2000 May 05.
Artículo en Inglés | MEDLINE | ID: mdl-10814848

RESUMEN

Chronic fluorosis can severely damage many systems of human body, but its pathogenesis is unclear. Normal composition and structure of cellular membrane lipids are a basic factor to maintain cell function. In this investigation, cellular membrane lipids of the liver were analysed after a long term fluoride treatment for rats and the results are discussed in order to give an explanation for the pathogenesis of this disease. Wistar rats were supplied with drinking water containing either 30 or 100 ppm fluoride (NaF) for seven months. Contents of phospholipid and neutral lipid in rat liver were analyzed by high-performance liquid chromatography, and fatty acid composition from individual phospholipids was measured by gas chromatography. Results showed that the total liver phospholipid content decreased in the rats treated with high dose of fluoride due to a lower content of phosphatidylethanolamine (PE), phosphatidylcholine (PC) and phosphatidylserine (PS). Among the fatty acid compositions of PE and PC in the livers of fluoride poisoned animals, the proportion of polyunsaturated fatty acids (20:4 and 22:6) decreased, whereas saturated fatty acids (16:0 and 18:0) increased. No changes could be detected in the amounts of liver cholesterol and dolichol. Total ubiquinone contents in rat liver were reduced by 11% in the group treated with 30 ppm fluoride and by 42% in the group treated with 100 ppm fluoride. In the subclasses of ubiquinone, both ubiquinone-9 and ubiquinoine-10 amounts decreased after fluoride treatment. These modifications of membrane lipids might be induced by oxidative stress, which might be an important factor in the pathogenesis of chronic fluorosis.


Asunto(s)
Fluoruros/toxicidad , Metabolismo de los Lípidos , Hígado/metabolismo , Animales , Colesterol/metabolismo , Dolicoles/metabolismo , Ácidos Grasos/metabolismo , Femenino , Hígado/efectos de los fármacos , Masculino , Fosfatidilcolinas/metabolismo , Fosfatidiletanolaminas/metabolismo , Fosfolípidos/metabolismo , Ratas , Ratas Wistar , Ubiquinona/metabolismo
4.
J Nutr ; 129(12): 2113-8, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10573536

RESUMEN

Coenzyme Q levels decrease during aging in most tissues and in the target organs of a number of diseases. The uptake of this lipid into the blood and other tissues was investigated in 6-wk-old male Sprague-Dawley rats after 3 wk of dietary supplementation. In addition to the natural form of coenzyme Q(10), acetylated and succinylated forms were also administered. Coenzyme Q(10) was taken up into the blood, but uptake was significantly greater in rats given the succinylated ( approximately 40%), and particularly, the acetylated forms ( approximately 70%). All three forms increased significantly the total coenzyme Q concentration in both the liver ( approximately 100%) and spleen ( approximately 130%). Coenzyme Q(10) and its esterified forms were not taken up into kidney, heart, muscle or brain. Intraportal and intraperitoneal administration of succinylated coenzyme Q(10) gave results similar to those obtained in the dietary experiments. Uptake of the dietary coenzyme Q(10) into the liver and spleen did not down-regulate the endogenous synthesis, i.e., the amounts of isolated coenzyme Q(9) did not change in these tissues. Thus, esterification of coenzyme Q increases the uptake of dietary lipid into the blood; however, the derivatization does not contribute to the elevation of coenzyme Q levels in various organs.


Asunto(s)
Ubiquinona/análogos & derivados , Acetilación , Animales , Coenzimas , Suplementos Dietéticos , Esterificación , Hígado/metabolismo , Masculino , Ratas , Ratas Sprague-Dawley , Bazo/metabolismo , Succinatos/metabolismo , Ubiquinona/administración & dosificación , Ubiquinona/sangre , Ubiquinona/química , Ubiquinona/metabolismo , Ubiquinona/farmacocinética
5.
Cell Mol Biol (Noisy-le-grand) ; 42(5): 683-90, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8832099

RESUMEN

Microsomal membranes from rat liver were extracted with n-pentane in order to remove the lipid products of the mevalonate pathway, dolichol, ubiquinone and cholesterol. Dolichol and cholesterol were subsequently reincorporated into these extracted membranes. Electron microscopic examination demonstrated that extraction did not alter the vesicular membrane structure of the microsomes. The extracted vesicles were permeable to uncharged molecules in the same manner as control microsomes but had an increased permeability for charged molecules. Enzyme denaturation was not observed. The contraction of extracted vesicles was greatly increased when the incubation medium was supplemented with non-penetrating compounds such as polyethylene glycol and was much greater than that of control microsomes. When extracted membranes were reconstituted with dolichol or cholesterol, the original lower degree of contraction was reestablished. The effects of dolichol reincorporation on a number of microsomal enzyme activities were investigated and some limited changes were observed. These results demonstrate that extraction of microsomes with n-pentane and subsequent reincorporation of dolichol is an effective approach for investigating the functions of this lipid. Dolichol and cholesterol both affect microsomal membrane fluidity, but only cholesterol modifies the activities of certain integral microsomal membrane enzymes to a larger extent.


Asunto(s)
Dolicoles/metabolismo , Microsomas Hepáticos/metabolismo , Animales , Colesterol/aislamiento & purificación , Colesterol/metabolismo , Dolicoles/aislamiento & purificación , Liofilización , Técnicas In Vitro , Membranas Intracelulares/metabolismo , Membranas Intracelulares/ultraestructura , Luz , Masculino , Fluidez de la Membrana , Microscopía Electrónica , Microsomas Hepáticos/ultraestructura , Tamaño de la Partícula , Pentanos , Ratas , Ratas Sprague-Dawley , Dispersión de Radiación
6.
Biochim Biophys Acta ; 1271(1): 195-204, 1995 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-7599208

RESUMEN

This presentation is a brief review of current knowledge concerning some biochemical, physiological and medical aspects of the function of ubiquinone (coenzyme Q) in mammalian organisms. In addition to its well-established function as a component of the mitochondrial respiratory chain, ubiquinone has in recent years acquired increasing attention with regard to its function in the reduced form (ubiquinol) as an antioxidant. Ubiquinone, partly in the reduced form, occurs in all cellular membranes as well as in blood serum and in serum lipoproteins. Ubiquinol efficiently protects membrane phospholipids and serum low-density lipoprotein from lipid peroxidation, and, as recent data indicate, also mitochondrial membrane proteins and DNA from free-radical induced oxidative damage. These effects of ubiquinol are independent of those of exogenous antioxidants, such as vitamin E, although ubiquinol can also potentiate the effect of vitamin E by regenerating it from its oxidized form. Tissue ubiquinone levels are regulated through the mevalonate pathway, increasing upon various forms of oxidative stress, and decreasing during aging. Drugs inhibiting cholesterol biosynthesis via the mevalonate pathway may inhibit or stimulate ubiquinone biosynthesis, depending on their site of action. Administration of ubiquinone as a dietary supplement seems to lead primarily to increased serum levels, which may account for most of the reported beneficial effects of ubiquinone intake in various instances of experimental and clinical medicine.


Asunto(s)
Enfermedad , Ubiquinona/fisiología , Animales , Antioxidantes/metabolismo , Antioxidantes/farmacología , Daño del ADN , Complejo III de Transporte de Electrones/metabolismo , Complejo IV de Transporte de Electrones/metabolismo , Humanos , Peroxidación de Lípido/efectos de los fármacos , Lipoproteínas LDL/sangre , Mamíferos , Lípidos de la Membrana/metabolismo , Proteínas de la Membrana/efectos de los fármacos , Proteínas de la Membrana/metabolismo , Modelos Biológicos , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Especificidad de Órganos , Oxidantes/metabolismo , Oxidantes/farmacología , Oxidación-Reducción , Fosfolípidos/metabolismo , Valores de Referencia , Ubiquinona/análogos & derivados , Ubiquinona/metabolismo , Ubiquinona/farmacología
7.
J Nutr ; 125(3): 446-53, 1995 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-7876919

RESUMEN

Coenzyme Q is an important mitochondrial redox component and the only endogenously produced lipid-soluble antioxidant. Its tissue concentration decreases with aging and in a number of diseases; dietary supplementation of this lipid would fulfill important functions by counteracting coenzyme Q depletion. To investigate possible uptake, rats were administered 12 mumol coenzyme Q10/100 g body wt once daily by gastric intubation. The appearance of coenzyme Q10 in various tissues and blood after 6 h, 4 d or 8 d was studied. The control group of rats received rapeseed-soybean oil (the vehicle in the experimental group). Lipids were extracted with petroleum ethermethanol, and the reduced and oxidized forms of coenzyme Q9 and Q10 were separated and quantified by reversed-phase HPLC. In the plasma, the total coenzyme Q concentration was doubled after 4 d of treatment. Coenzyme Q10 was also recovered in liver homogenates, where, as in the plasma, it was largely in the reduced form. Uptake into the spleen could be to a large extent accounted for by the blood content of this organ. No dietary coenzyme Q10 was recovered in the heart or kidney. The uptake in the whole body was 2-3% of the total dose. Coenzyme Q10 found in the liver was located mainly in the lysosomes. Dietary coenzyme Q10 did not influence the endogenous biosynthesis of coenzyme Q9. This is in contrast to dietary cholesterol, which down-regulates cholesterol biosynthesis. The dietary coenzyme Q10 level in the plasma decreased to approximately 50% after 4 d. These results suggest that dietary coenzyme Q10 may play a role primarily in the blood and that no appreciable uptake occurs into tissues.


Asunto(s)
Dieta , Ubiquinona/farmacocinética , Animales , Cromatografía Líquida de Alta Presión , Intubación Gastrointestinal , Riñón/metabolismo , Cinética , Hígado/metabolismo , Hígado/ultraestructura , Masculino , Ácido Mevalónico/metabolismo , Miocardio/metabolismo , Ratas , Ratas Sprague-Dawley , Bazo/metabolismo , Fracciones Subcelulares/metabolismo , Tritio , Ubiquinona/administración & dosificación , Ubiquinona/sangre
8.
J Biol Chem ; 268(2): 1494-9, 1993 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-8419349

RESUMEN

The localization of ubiquinone (UQ) and plastoquinone (PQ) biosynthesis in subfractions isolated from spinach leaves has been studied. UQ-9 and UQ-10 were found mainly in mitochondria, whereas PQ was enriched in chloroplasts, but also found in Golgi membranes. alpha-Unsaturated polyprenol-11 was also present at a low concentration in chloroplasts. Autoradiography revealed the presence of nonaprenyl-4-hydroxybenzoate (NPHB) and nonaprenyl-2-methylquinol (NPMQ) transferase activities involved in quinone biosynthesis in all subfractions, but the specific activities involved in quinone biosynthesis in the total microsomal fraction were 20 times higher than those in mitochondria and chloroplasts. The isolated Golgi vesicles were particularly enriched in both activities. When the incubation medium containing total microsomes or Golgi membranes was supplemented with NADH, NADPH, S-adenosylmethionine, and an ATP-generating system, NPHB and NPMQ were transferred to UQ-9 and PQ, respectively. trans-Prenyltransferase, which synthesizes the side chain of UQ and PQ, was present in the total microsomal fraction. With farnesyl-PP as substrate, no product was formed, but with geranyl-PP, solanesyl-PP was synthesized and transferred to 4-hydroxybenzoate present in the total microsomal fraction. The results show that these membranes from spinach contain farnesyl-PP synthetase. It is concluded that the plant leaf Golgi membranes contain the enzymes for both UQ and PQ biosynthesis and that a specific transport and targeting system is required for selective transfer of UQ to the mitochondria and of PQ to the chloroplast.


Asunto(s)
Retículo Endoplásmico/metabolismo , Aparato de Golgi/metabolismo , Plantas/metabolismo , Plastoquinona/metabolismo , Ubiquinona/biosíntesis , Fraccionamiento Celular , Cloroplastos/metabolismo , Citosol/metabolismo , Dimetilaliltranstransferasa/metabolismo , Ácido Mevalónico/metabolismo , Microsomas/metabolismo , Mitocondrias/metabolismo , NAD/metabolismo , NADP/metabolismo , Oxidación-Reducción , S-Adenosilmetionina/metabolismo , Fracciones Subcelulares/metabolismo , Transferasas/metabolismo
9.
Lipids ; 26(11): 915-21, 1991 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1805096

RESUMEN

The influence of different fat diets on liver phospholipid, cholesterol and dolichol was studied. Rats were separated into four groups and fed standard laboratory chow (control), a diet containing linolenic acid, a coconut oil diet, or a corn oil-containing diet. After five weeks, microsomes and mitochondrial/lysosomal fractions were prepared from the liver, and lipid compositions were analyzed. No changes in phospholipid content were observed. In control animals, the fatty acid compositions of phosphatidylcholine and phosphatidylethanolamine in the two subfractions were similar. However, these two phospholipids showed different fatty acid patterns, which were altered independently upon dietary treatment. The dietary treatments resulted, in most cases, in decreased cholesterol and dolichol contents and, especially in microsomes, in a decreased level of esterification of both lipids. The fatty acid compositions of cholesteryl esters in the two subfractions showed significant differences and cholesterol was esterified to a large extent with linolenic acid when this fatty acid was supplied in the diet. The same dietary treatment exerted different effects on the cholesterol localized in the two different intracellular compartments. This difference was most pronounced in rats fed the corn oil-containing diet; microsomal cholesteryl esters exhibited increased saturation, whereas cholesteryl esters exhibited increased saturation, whereas cholesteryl esters in the mitochondrial/lysosomal fraction displayed decreased saturation. Dolichyl esters in the two cellular compartments had different fatty acyl compositions, with a considerably higher degree of saturation in microsomes. The various diets influenced the nature of the fatty acid moieties present in the isolated fractions and the effects on the two subfractions were opposite.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Grasas de la Dieta/farmacología , Lípidos/análisis , Hígado/química , Fracciones Subcelulares/química , Animales , Colesterol/análisis , Aceite de Coco , Aceite de Maíz/farmacología , Dolicoles/análisis , Ácidos Grasos/análisis , Ácidos Linolénicos/farmacología , Hígado/efectos de los fármacos , Lisosomas/química , Lisosomas/efectos de los fármacos , Masculino , Microsomas/química , Microsomas/efectos de los fármacos , Mitocondrias/química , Mitocondrias/efectos de los fármacos , Fosfolípidos/análisis , Aceites de Plantas/farmacología , Ratas , Ratas Endogámicas , Fracciones Subcelulares/efectos de los fármacos
10.
Lipids ; 26(6): 421-5, 1991 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-1881238

RESUMEN

The two major phospholipid classes, namely, phosphatidylethanolamines (PE) and phosphatidylcholines (PC), were studied in four different regions of human brain, i.e., in frontal gray matter, frontal white matter, hippocampus and in pons. The fatty acid (FA) compositions of these phospholipids were found to be specific for the different regions. PC contains mostly saturated and 18:1 FA, while PE is rich in polyunsaturated FA. Aging has no influence on the FA compositions, while in Alzheimer's disease (AD) PE is modified in all four regions, particularly in frontal gray matter and in hippocampus. The abundance of the major monounsaturated FA of PE, 18:1, is not significantly altered in Alzheimer's disease, but there is a substantial increase in the relative amounts of the saturated components 14:0, 16:0 and 18:0. This is paralleled by a decrease in the polyunsaturated FA 20:4, 22:4 and 22:6. It is not clear whether the changes observed are specific for AD. Changes in saturated/polyunsaturated FA ratio are likely to influence cellular function, which in turn may cause certain neural deficiencies. The findings do not support the hypothesis that AD reflects an accelerated aging process.


Asunto(s)
Envejecimiento/metabolismo , Enfermedad de Alzheimer/metabolismo , Encéfalo/metabolismo , Ácidos Grasos/metabolismo , Fosfolípidos/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Lóbulo Frontal/metabolismo , Hipocampo/metabolismo , Humanos , Persona de Mediana Edad , Fosfatidilcolinas/metabolismo , Fosfatidiletanolaminas/metabolismo , Puente/metabolismo
11.
J Cell Biol ; 30(1): 97-117, 1966 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-4381698

RESUMEN

The constitutive enzymes of microsomal membranes were investigated during a period of rapid ER development (from 3 days before to 8 days after birth) in rat hepatocytes. The activities studied (electron transport enzymes and phosphatases) appear at different times and increase at different rates. The increase in the enzyme activities tested was inhibited by Actinomycin D and puromycin. G-6-Pase and NADPH-cytochrome c reductase activities appeared first in the rough microsomes, and subsequently in smooth microsomes, eventually reaching a uniform concentration as in adult liver. The evidence suggests that the enzymes are synthesized in the rough part, then transferred to the smooth part, of the ER. Changes in the fat supplement of the maternal diet brought about changes in the fatty acid composition of microsomal phospholipids but did not influence the enzymic pattern of the suckling. Microsomes from 8-day-old and adult rats lose 95% of PLP and 80% of NADH-cytochrome c reductase activity after acetone-H(2)O (10:1) extraction. However, one-half the original activity could be regained by adding back phospholipid micelles prepared from purified phospholipid, or from lipid extracts of heart mitochondria, or of liver microsomes of 8-day or adult rats, thus demonstrating an activation of the enzyme by nonspecific phospholipid. The results suggest that during development the enzymic pattern is not influenced by the fatty acid or phospholipid composition of ER membranes.


Asunto(s)
Retículo Endoplásmico , Hígado/citología , Microsomas/enzimología , Animales , Animales Recién Nacidos , Dactinomicina/análisis , Dactinomicina/farmacología , Grasas de la Dieta , Transporte de Electrón , Complejo IV de Transporte de Electrones/análisis , Ácidos Grasos/análisis , Glucosa-6-Fosfatasa/análisis , Histocitoquímica , Hígado/enzimología , Membranas , Microscopía Electrónica , Mitocondrias/análisis , NADP/análisis , Fosfolípidos/análisis , Monoéster Fosfórico Hidrolasas/análisis , Puromicina/análisis , Puromicina/farmacología , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA